solutol hs 15 has been researched along with paclitaxel in 4 studies
Studies (solutol hs 15) | Trials (solutol hs 15) | Recent Studies (post-2010) (solutol hs 15) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
92 | 1 | 59 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alani, AW; Jiao, J; Kwon, GS; Rao, DA; Seidel, R; Wang, J | 1 |
Chen, L; Deng, Y; Gao, Y; Ji, X; Li, Y; Zhang, Z | 1 |
Hou, J; Jia, XB; Sun, C; Sun, E; Wang, J; Yang, L; Zhang, ZH | 1 |
Li, W; Xu, H; Xue, J | 1 |
4 other study(ies) available for solutol hs 15 and paclitaxel
Article | Year |
---|---|
The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.
Topics: Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Humans; L-Lactate Dehydrogenase; Light; Mannitol; Micelles; Paclitaxel; Polyethylene Glycols; Scattering, Radiation; Solubility; Stearic Acids; Surface-Active Agents | 2010 |
Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Compounding; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycerol; Humans; Lipids; Liposomes; Lung Neoplasms; Nanotechnology; Paclitaxel; Particle Size; Poloxamer; Polyethylene Glycols; Rhodamine 123; Solubility; Stearic Acids; Surface-Active Agents; Technology, Pharmaceutical; Time Factors | 2012 |
Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Male; Mice; Micelles; Paclitaxel; Polyethylene Glycols; Polymers; Polyvinyls; Rats; Stearic Acids; Xenograft Model Antitumor Assays | 2016 |
Combined administration of PTX and S-HM-3 in TPGS/Solutol micelle system for oncotarget therapy.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Movement; Drug Carriers; Female; Humans; Inhibitory Concentration 50; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Neoplasms; Paclitaxel; Polyethylene Glycols; Stearic Acids; Tissue Distribution; Tumor Burden; Vitamin E; Whole Body Imaging | 2019 |